Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human csf-1r monoclonal antibody and use thereof

A CSF-1R and monoclonal antibody technology, applied in the direction of antibodies, anti-animal/human immunoglobulins, applications, etc., can solve problems that need further research and development, and achieve the effect of novel sequences

Active Publication Date: 2020-07-28
BIOSION INC
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although CSF1R antibodies have been developed, CSF1R inhibitors with higher affinity and other key properties of drugs for the treatment of the above diseases, especially monoclonal antibodies, still need to be further researched and developed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human csf-1r monoclonal antibody and use thereof
  • Anti-human csf-1r monoclonal antibody and use thereof
  • Anti-human csf-1r monoclonal antibody and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1 obtains the mouse monoclonal antibody of specific anti-CSF1R by fusion hybridoma technology

[0036] 1.1 Animal immunity

[0037] Mice were immunized according to the general method in the literature (E Harlow, D. Lane, Antibody: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1998). The immunogen is a recombinant human CSF1R (amino acid interval Ile20-Glu 512) protein (Acrobiosystems, Cat#CSR-H5258) containing a human IgG1 Fc tag at the C-terminus. Recombinant human CSF1R protein with his tag (Acro biosystems, cat#CSR-H5228) was used as the detection antigen for determination of serum titer and hybridoma screening. Briefly, remove an appropriate amount of Freund's adjuvant into a 1.5ml EP tube, and shake to mix. Prepare the antigenic protein solution with PBS. Mix the adjuvant and protein antigen solution according to the required amount, fully emulsify the antigen by pushing each other through the syringe to form a s...

Embodiment 2

[0043] Example 2 In vitro assay method for measuring CSF1R monoclonal antibody functional activity

[0044] 2.1 Determination of antibody binding ability based on capture ELSIA

[0045] Prepare goat anti-mouse IgG Fcr-specific secondary antibody (Jackson Immuno Research, #115-006-071) in 1xPBS to a final concentration of 2 μg / ml, add 100 μl / well to a 96-well microtiter plate, 4 degrees Pack overnight. The next day, after washing the plate 4 times with PBS solution containing 0.05% Tween 20 (ie 1xPBST), 200 μl / well of 5% skim milk powder in PBST solution was added and placed at 37°C for 2 hours to block. Wash the plate again, add 100 μl / well of diluted antibody solution or hybridoma supernatant, incubate at 37 degrees for 40 minutes, and then wash the plate 4 times. Add the prepared 60 nM biotin-labeled human CSF1R Fc protein solution (in 2.5% skimmed milk powder in PBST) at 100 μl / well, incubate at 37°C for 40 minutes, and then wash the plate 4 times. Add 1:10000 dilution o...

Embodiment 3

[0055] Example 3 Binding activity of anti-CSF1R mouse monoclonal antibody

[0056] According to the analysis method described in Example 2, the evaluation of binding activity of CSF1R antibody is summarized in Table 2. Among them, Benchmark (Cabiralizumab) is used as a control, which is an existing non-commercialized anti-human CSF1R monoclonal antibody. It can be seen from Table 2 that the binding activity of the anti-human CSF-1R monoclonal antibody of the present invention to human CSF1R antigen is significantly better than that of Benchmark.

[0057] Table 2 Binding activity of purified CSF1R mouse monoclonal antibody

[0058]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an anti-human CSF-1R monoclonal antibody and application, and also provides coding nucleic acid molecules, an expression carrier, host cells of the antibody and a method for expressing the antibody, and also provides an antibody immune coupling binder including the antibody disclosed by the invention, bispecific molecules, embedded antigen receptors, pharmaceutical compositions and application. Compared with the prior art, the anti-human CSF-1R monoclonal antibody disclosed by the invention has the following advantages that monoclonal antibody of human CSF-1R can be specially identified, and the affinity of bonding of the antibody and the human CSF-1R is stronger than that of an existing anti-human CSF-1R monoclonal body, and the sequence of the antibody is novel.

Description

technical field [0001] The invention relates to a high-affinity and functional anti-human CSF1R monoclonal antibody or antibody fragment. The present invention also provides the encoding nucleic acid molecules of the antibody, expression vectors, host cells, and methods for expressing the antibody. Also provided are antibody immunoconjugates, bispecific molecules, chimeric antigen receptors, pharmaceutical compositions, and diagnostic and therapeutic methods comprising antibodies of the invention. Background technique [0002] Colony-stimulating factor 1 receptor (CSF-1R), which belongs to the type III receptor tyrosine kinase family, is encoded by the proto-oncogene c-fms. The ligand-binding domain of a protein-like structure. CS1R is expressed on the surface of mononuclear phagocytes and plays a key role in the survival, proliferation and differentiation of mononuclear phagocytes (Felix, et al., (2015) Structure 23, 1621-1631). And CSF1R is also highly expressed on the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13A61K39/395A61P35/00A61P19/02A61P29/00A61P9/10A61P19/00
CPCA61P9/10A61P19/00A61P19/02A61P29/00A61P35/00C07K16/2866C07K2317/56C07K2317/565C07K2317/76C07K2317/92
Inventor 陈明久谭巍
Owner BIOSION INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com